Literature DB >> 33401389

Angioedema and COVID-19: A New Dermatological Manifestation?

Pierre-Yves Royer1, Souheil Zayet1, Claire Jacquin-Porretaz2, N'dri Juliette Kadiane-Oussou1, Lynda Toko1, Vincent Gendrin1, Timothée Klopfenstein1.   

Abstract

The main localization of SARS-CoV-2 infection is the respiratory tract. Digestive and otorhinolaryngological localizations are also reported. More recently, dermatological manifestations have been reported during Coronavirus disease-19 (COVID-19). We report a case of a labial angioedema in a patient with confirmed COVID-19.

Entities:  

Keywords:  COVID-19; angioedema; dermatology

Year:  2021        PMID： 33401389      PMCID： PMC7838910          DOI： 10.3390/idr13010004

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN： 2036-7430


  10 in total

Review 1.  Association between urticaria and virus infections: A systematic review.

Authors:  Egidio Imbalzano; Marco Casciaro; Sebastiano Quartuccio; Paola L Minciullo; Antonio Cascio; Gioacchino Calapai; Sebastiano Gangemi
Journal:  Allergy Asthma Proc       Date:  2015-12-03       Impact factor: 2.587

2.  [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].

Authors:  Y Zhang; W Cao; M Xiao; Y J Li; Y Yang; J Zhao; X Zhou; W Jiang; Y Q Zhao; S Y Zhang; T S Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-03-28

3.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

4.  The occurrence of diarrhea in COVID-19 patients.

Authors:  Xiang-Yu Li; Wei-Jie Dai; Shang-Nong Wu; Xiao-Zhong Yang; Hong-Gang Wang
Journal:  Clin Res Hepatol Gastroenterol       Date:  2020-04-03       Impact factor: 2.947

5.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.

Authors:  Jerome R Lechien; Carlos M Chiesa-Estomba; Daniele R De Siati; Mihaela Horoi; Serge D Le Bon; Alexandra Rodriguez; Didier Dequanter; Serge Blecic; Fahd El Afia; Lea Distinguin; Younes Chekkoury-Idrissi; Stéphane Hans; Irene Lopez Delgado; Christian Calvo-Henriquez; Philippe Lavigne; Chiara Falanga; Maria Rosaria Barillari; Giovanni Cammaroto; Mohamad Khalife; Pierre Leich; Christel Souchay; Camelia Rossi; Fabrice Journe; Julien Hsieh; Myriam Edjlali; Robert Carlier; Laurence Ris; Andrea Lovato; Cosimo De Filippis; Frederique Coppee; Nicolas Fakhry; Tareck Ayad; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-06       Impact factor: 2.503

Review 6.  COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Authors:  Piercarlo Sarzi-Puttini; Valeria Giorgi; Silvia Sirotti; Daniela Marotto; Sandro Ardizzone; Giuliano Rizzardini; Spinello Antinori; Massimo Galli
Journal:  Clin Exp Rheumatol       Date:  2020-03-22       Impact factor: 4.473

7.  Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.

Authors:  C Galván Casas; A Català; G Carretero Hernández; P Rodríguez-Jiménez; D Fernández-Nieto; A Rodríguez-Villa Lario; I Navarro Fernández; R Ruiz-Villaverde; D Falkenhain-López; M Llamas Velasco; J García-Gavín; O Baniandrés; C González-Cruz; V Morillas-Lahuerta; X Cubiró; I Figueras Nart; G Selda-Enriquez; J Romaní; X Fustà-Novell; A Melian-Olivera; M Roncero Riesco; P Burgos-Blasco; J Sola Ortigosa; M Feito Rodriguez; I García-Doval
Journal:  Br J Dermatol       Date:  2020-06-10       Impact factor: 11.113

8.  Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.

Authors:  Chi Zhang; Zhao Wu; Jia-Wen Li; Hong Zhao; Gui-Qiang Wang
Journal:  Int J Antimicrob Agents       Date:  2020-03-29       Impact factor: 5.283

Review 9.  Urticarial eruption in COVID-19 infection.

Authors:  D Henry; M Ackerman; E Sancelme; A Finon; E Esteve
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06       Impact factor: 9.228

Review 10.  Cutaneous manifestations in COVID-19: a new contribution.

Authors:  A Estébanez; L Pérez-Santiago; E Silva; S Guillen-Climent; A García-Vázquez; M D Ramón
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06       Impact factor: 9.228
  10 in total
  2 in total

Review 1.  Long-Term Effects of COVID-19.

Authors:  Shreeya Joshee; Nikhil Vatti; Christopher Chang
Journal:  Mayo Clin Proc       Date:  2022-01-12       Impact factor: 7.616

2.  An infant with COVID-19 presenting with acute urticaria and angioedema.

Authors:  Öner Özdemir; Emine A Yılmaz; Muhammet Mesut N Engin
Journal:  Int J Dermatol       Date:  2021-07-18       Impact factor: 3.204
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.